Search

  • Home
  • News
    • GenomeWeb Daily News
    • BioArray News
    • BioInform
    • Clinical Sequencing News
    • Gene Silencing News
    • In Sequence
    • PCR Insider
    • PGx Reporter
    • ProteoMonitor
  • Magazine
  • Blog
    • The Daily Scan
    • Cancer Minute
    • Informatics Iron
    • The Sample
  • Careers
    • Job Listings
  • Video
  • Resource

Log in or Register
Saturday, May 19, 2012
  • Arrays
  • MDx
  • Informatics
  • PCR/Sample Prep
  • Proteomics
  • RNAi
  • Sequencing
  • Videos
Please note that you must have cookies enabled in your browser to access content on our site.
If you have questions, please contact customerservice@genomeweb.com.

GenomeWeb Daily News

  • NIGMS to Provide $10M for Systems Bio Research Centers
  • Study Finds Low Methylation Regions Prone to Structural Mutation
  • UC-Riverside Researchers Receive $1.5M NIH Grant for Research into Nuclear Receptors
  • Bio Products to Distribute Phthisis Diagnostics Products in Latin America
  • In Brief This Week: Agilent; Waters; Vermillion, Quest Diagnostics; WaferGen; IntelligentMDx; Lineagen; Plexpress; Champions Oncology
See more headlines

BioArray News

  • Lineagen to Update Autism Microarray Test with New Variants Discovered by CHOP, University of Utah
  • Finnish CRO Admescope Adopts Plexpress' TRAC Platform for ADME-Tox Services
  • Array-Based Tests Advance as Dx Firms Engage FDA, Raise Capital, Report Revenue Growth
See all

BioInform

  • COMBREX Developers Seek Stable Funding to Guarantee Survival of Gene Function Validation Project
  • Bioinformatics Consultancy Diatom Software Looks to Carve a Niche in Pharma, Biotech Markets
  • SimulConsult Launches Software to Link Genomic, Clinical, and Phenotypic Data
See all

Clinical Sequencing News

  • Adaptive Biotech Targets Year End for CLIA Certification, Assay to Detect Residual Leukemia
  • Startup Aims to Translate Hopkins Team's Cancer Genomics Expertise into Patient Care
  • UBC Team Uses Ion's AmpliSeq Cancer Panel to Find Rare Mutation in Pediatric Brain Tumor
See all

Gene Silencing News

  • Rosetta Stock Rises on Reverse Stock Split, Kidney Test Launch, Medicare Coverage of CUP Dx
  • Tekmira Official Sees 'Resolution' to Alnylam Dispute Before Year End
  • University of Utah Aims to Keep RNAi IP Suit Against UMass Officials on Track
See all

In Sequence

  • Biology of Genomes Presentations Highlight Burgeoning Single-Cell Sequencing Approaches
  • In Letter to Nature Biotech, Ion Torrent Claims Bias in Desktop Sequencer Comparison
  • Q&A: Detlef Weigel on the Impact of Next-Gen Sequencing on Plant Genomics Research
See all

PCR Insider

  • Alere Developing Pair of NAT Platforms with Initial Assays Planned for HIV Viral Load, Flu
  • Fluidigm Developing Cellular Sample Prep Platform for Single-Cell Gene Expression, NGS Studies
  • UK's DSTL Demonstrates Use of Life Tech TaqMan Array Cards to Detect Multiple Biological Agents
See all

Pharmacogenomics Reporter

  • As PCORI Looks to Finalize Priorities, Commitment to Personalized Rx Remains Unclear
  • With Celgene Partnership Epizyme Hopes to Accelerate Personalized Epigenetic Drug Development
  • Molecular Screening Awareness Grows in Step with Adoption of Roche Melanoma Drug, Survey Finds
See all

ProteoMonitor

  • GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build
  • Vermillion's Q1 Revenues Decline 28 Percent, CEO Page Stepping Down
  • New Assay Could Aid Study of Brief Protein Interactions, Interpretation of Phosphoproteomic Work
See all
  • Most Viewed
  • Most Emailed
  • Blog
  1. GenomeWeb Daily News
    Coventry Terminates Deal with Sequenom; Further Data Published on MaterniT21 Plus Test
  2. GenomeWeb Daily News
    NIGMS to Provide $10M for Systems Bio Research Centers
  3. GenomeWeb Daily News
    Study Finds Low Methylation Regions Prone to Structural Mutation
  4. GenomeWeb Daily News
    In Brief This Week: Agilent; Waters; Vermillion, Quest Diagnostics; WaferGen; IntelligentMDx; Lineagen; Plexpress; Champions Oncology
  5. GenomeWeb Daily News
    People In The News
  1. Cancer Minute
    The Importance of Acknowledgement
  2. Cancer Minute
    This Week in Cancer Discovery
  3. Clinical Sequencing News
    Adaptive Biotech Targets Year End for CLIA Certification, Assay to Detect Residual Leukemia
  4. BioInform
    COMBREX Developers Seek Stable Funding to Guarantee Survival of Gene Function Validation Project
  5. BioInform
    Bioinformatics Consultancy Diatom Software Looks to Carve a Niche in Pharma, Biotech Markets
  1. The Daily Scan
    An Interview with Craig Venter
  2. The Daily Scan
    This Week in Science
  3. Careers
    'A Symbiotic Relationship'
  4. The Daily Scan
    Political Science
  5. The Daily Scan
    In Charge of Research
  • Video Spotlight

    Shashikant Kulkarni at ACMG

    See video

    BioArray News editor Justin Petrone sat down with Shashikant Kulkarni, an associate professor at Washington University School of Medicine at St. Louis, to discuss chromosomal microarrary analysis in the clinic, SNP arrays versus CGH platforms for post-natal testing, and more.

    May 16, 2012

    Miragen Therapeutics' Eva van Rooij

    See video

    Miragen Therapeutics' Eva van Rooij discusses microRNA-based therapeutics, the challenges associated with chronic microRNA knockdown, therapeutic microRNA antagonists, and more.

    May 08, 2012

    A Conversation with CeGaT's Saskia Biskup

    See video

    In this video, Julia Karow, Editor of Clinical Sequencing News, interviews Saskia Biskup, CEO of the Center for Genomics and Transcriptomics, or CeGaT, at the company's headquarters in Tübingen, Germany.

    May 02, 2012

    A Tour of Illumina's CLIA Lab

    See video

    In this video, Illumina's CLIA laboratory manager Suneer Jain gives InSequence and Clinical Sequencing News Editor Monica Heger a tour of Illumina's CLIA lab at the company's San Diego headquarters.

    April 25, 2012
  • Young Investigator Profile

    Vincent Fusaro

    Harvard Medical School
    Postdoctoral Fellow

    Informatics and PGx

    Vincent Fusaro is using a Pathways to Independence grant from the National Library of Medicine to develop informatics methods for identifying new uses for existing drugs as well as confirming their benefit using electronic medical records from health-care providers.

  • Blog

    This Week in the Journal of Molecular Diagnostics

    In the Journal of Molecular Diagnostics this week: long-range PCR to detect PKD1 and PKD2 mutations, more.

    May 18, 2012

    An Accreditation Module

    The College of American Pathologists teams up with SoftTech Health.

    May 18, 2012

    Political Science

    Sometimes, researchers have to get political, says one writer.

    May 18, 2012

    In Charge of Research

    Geneviève Fioraso is the new French research minister.

    May 18, 2012
  • Papers of Note

    KCTD13 a Driver of Neurodevelopmental Phenotypes Associated with the 16p11.2 CNV
    Golzio, Willer et al., Nature
    An international team led by investigators at Duke University shows that KCTD13 "is a major driver for the neurodevelopmental phenotypes associated with the 16p11.2 CNV [copy-number variant]," a finding that it says substantiates "the idea that one or a small number of transcripts within a CNV can underpin clinical phenotypes, and offer an efficient route to identifying dosage-sensitive loci."

    Approach to Reduce Allelic Bias in RNA-seq Read-Mapping
    Satya, Zavaljevski, and Reifman, Nucleic Acids Research
    Researchers at the US Department of Defense Biotechnology High Performance Computing Software Applications Institute present an approach to reduce allelic bias in RNA-seq read-mapping based on the "construction of an enhanced reference genome that includes the alternative alleles at known polymorphic loci." In this paper, the team shows that "mapping to this enhanced reference reduced the read-mapping biases, leading to more reliable estimates of ASE [allele-specific expression]."

  • People on the Move

    IntegenX has appointed David Smith to serve as its new COO. Smith most recently served as CFO of Thoratec, and previous to that was CFO at Chiron. He currently is chair of the audit committee and a director of OncoGenex Pharmaceuticals and previously was chair of the audit committee and a director of Perlegen Sciences.


    Vermillion said this week that President and CEO Gail Page will be leaving the company by September and the firm has begun the process to find her successor. Page also has resigned her seat on the board of directors, and effective immediately Vermillion amended its bylaws to eliminate the vacant seat, reducing its board from seven to six members.


    Genomic Health has appointed Richard Tompane as president of its new subsidiary InVitae, which will focus on developing next-generation-based sequencing diagnostics for genetic diseases. Tompane was previously president and CEO of Gemfire and has also served as an independent consultant.

  • Upcoming Events

    Conferences, Meetings & Deadlines

    The iMedicine & Mobile Life Sciences World Summit
    May 16-17 / Boston
    Arrowhead Publishers

    New Perspectives on Immunity to Infection
    May 19-22 / Heidelberg, Germany
    EMBL

    TIDES: Oligonucleotides and Peptide Technology & Product Development
    Applications of Nucleic Acids Technologies in Molecular Diagnostics, Oligonucleotide Therapeutics Discovery, and Peptide Discovery and Development

    May 20-23 / Las Vegas
    IBC Life Sciences

    Microtubules: Structure, Regulation and Functions
    May 23-26 / Heidelberg, Germany
    EMBL

    Evidence for Clinical Utility of Molecular Diagnostics in Oncology: A Workshop
    May 24 / Washington, DC
    Institute of Medicine

    Abstract & Registration Deadlines

    more
  • Science

    A study published in Science Translational Medicine suggests high-throughput sequencing is effective for finding post-treatment leukemia cells that can lead to patient relapse. Researchers used sequencing to test matched pre- and post-chemotherapy samples from 43 individuals with T-lineage acute lymphoblastic leukemia. They found that the sequencing method tracked down minimal residual disease in 25 of the cases tested, including several missed by flow cytometry.
  • Business

    Agilent Technologies will spend $2.2 billion to acquire Danish diagnostics firm Dako. The deal marks a major push by Agilent into the diagnostics arena and provides the firm with Dako's portfolio of immunohistochemical cancer diagnostic tools and emerging companion diagnostics alliances as well as an entry into the $2.2 billion anatomic pathology market. Dako is expected to generate $373 million in revenues in fiscal 2013 with a $68 million operating profit.
  • Funding

    The National Institute on Aging will provide up to $6 million in 2013 to support up to three projects undertaking whole exome and/or whole genome sequencing data analysis to identify genomic contributions to both the risk for and protection against Alzheimer's disease. The funding program is part of the Presidential Initiative on Alzheimer's Disease and is expected to fund between one and three awards with up to $2 million direct cost per award for fiscal year 2013.
  • Genome Technology Magazine

    For this month's Q&A, Matthew Dublin speaks with McGill University's John Breitner about a European consortium that aims to develop molecular diagnostics for both Alzheimer's and Parkinson's disease. As part of the program, Breitner is developing standardized ways to describe patient samples as a first step in bringing innovations to the clinic. Breitner says that there are a number of biomarkers than can confirm or deny a presumptive diagnosis, but there is not yet a standard way to run tests based on such markers.

TechGuides Listings

  • Transcriptomics Technical Guide
  • Tech Guide Archives

Poll

Copyright © 2012 Genomeweb LLC. All rights reserved. About | FAQ | Subscriptions | Contact us